Lates News

According to Every AI flash news, China Merchants Securities issued a research report on April 7th, giving Chongqing Spring Medical (688236.SH) a "buy" rating. The main reasons for the rating include: 1) The impact of centralized procurement has been cleared, and performance has achieved rapid growth; 2) Overseas markets are expanding rapidly, with impressive revenue performance; 3) Significant cost reduction and efficiency improvement, steadily increasing profitability. (Daily Economic News)